Patent Yard Sign in
Expired Canadian patentCanada

Nucleic acid amplification using non-standard bases

CA 2513626 C · Owner: Moser, Michael J. · Inventors: Prudent, James R.; Marshall, David J.; Moser, Michael J.

CIPO record

Overview

Drawings and full text

Its claims, description and drawings are in the Canadian Patents Database.

Open the CIPO record

Abstract From the Canadian patent

The present invention provides methods kits and compositions for high , fidelity nucleic acid amplification reactions of target nucleic acids such that specific amplification products that incorporate non-standard bases are produced. The amplification reactions can either be linear or exponential. In some embodiments, the fidelity of the amplification reaction is high enough such that a majority of the amplification products maintain non-standard bases at specific sites designated by the user after a specified number of amplification cycles. In some embodiments the ratio of non-standard , nucleoside triphosphates is greater than the amount of standard nucleoside triphosphates …

Read the whole patent

Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Filed January 17, 2004 and granted March 19, 2013. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended January 17, 2024.
  • A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by January 17, 2026.
  • We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledJanuary 17, 2004
GrantedMarch 19, 2013
Term endedJanuary 17, 2024
Patent numberCA 2513626 C
Classification (IPC)C12P19/34

Timeline

Timeline From CIPO dates

2005200720092011201320152017201920212023Application filedJan 17, 2004Patent grantedMarch 19, 2013Term endedJan 17, 2024

Sources & verification

Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.